Fetal growth restriction (FGR) complicates approximately 3-7% of pregnancies and is associated with increased perinatal morbidity and mortality, including a heightened risk of neurodevelopmental impairment. Identifying which fetuses are most vulnerable to brain injury remains a clinical challenge, necessitating improved antenatal surveillance strategies.
Fetal growth restriction (FGR), defined as a fetus failing to reach its genetic growth potential, is a significant obstetric complication. It is linked to adverse perinatal outcomes, including stillbirth, neonatal death, and long-term neurodevelopmental deficits.1 The underlying pathophysiology often involves placental insufficiency, leading to chronic hypoxia and nutrient deprivation.2 This chronic stress can trigger adaptive circulatory changes in the fetus, commonly referred to as 'brain sparing,' where blood flow is preferentially redirected to vital organs like the brain at the expense of other circulations.3 While initially protective, prolonged brain sparing can itself indicate significant fetal compromise and is associated with an increased risk of brain injury.4
Doppler Ultrasound in FGR Assessment
Doppler ultrasound is a non-invasive tool used to assess fetal haemodynamics, providing insights into placental function and fetal adaptation to hypoxia. Key parameters include the umbilical artery (UA) pulsatility index (PI), which reflects placental resistance, and the middle cerebral artery (MCA) PI, which indicates cerebral vascular resistance.5 The cerebroplacental ratio (CPR), calculated as MCA PI divided by UA PI, is considered a more sensitive marker of fetal compromise than either parameter alone, as it reflects the balance between placental resistance and cerebral vasodilation.6 A low CPR is indicative of brain sparing and is associated with adverse perinatal outcomes.7
Studies have consistently demonstrated that abnormal Doppler parameters, particularly a low CPR, correlate with an increased risk of neonatal brain injury in FGR fetuses. For instance, a reduced MCA PI, reflecting cerebral vasodilation, has been linked to an increased incidence of white matter injury (WMI) and intraventricular haemorrhage (IVH) in preterm FGR infants.8 WMI, characterised by damage to the developing white matter, is a major precursor to cerebral palsy and other neurodevelopmental impairments.9 Similarly, abnormal UA Doppler findings, such as absent or reversed end-diastolic flow, are strong predictors of severe placental insufficiency and are associated with higher rates of neonatal morbidity and mortality, including neurological complications.10
The utility of Doppler assessment extends beyond risk stratification; it also informs clinical management, particularly regarding the timing of delivery. In FGR pregnancies, serial Doppler surveillance helps clinicians monitor the progression of fetal compromise. Deterioration in Doppler parameters, such as a persistently low CPR or absent/reversed UA end-diastolic flow, often prompts earlier delivery to mitigate the risks of stillbirth and severe neurological injury.11 The decision to deliver is a balance between the risks of prematurity and the risks of continued intrauterine compromise. Doppler findings provide objective data to guide this complex decision-making process.12
While Doppler ultrasound is a valuable tool, it has limitations. The interpretation of Doppler waveforms requires expertise, and inter-observer variability can occur.13 Furthermore, while Doppler abnormalities identify fetuses at increased risk, they do not predict brain injury with 100% accuracy. Other factors, such as gestational age at delivery, severity of FGR, and postnatal complications, also influence neurodevelopmental outcomes.14 Future research may focus on integrating Doppler parameters with other biomarkers and advanced imaging techniques, such as fetal MRI, to refine the prediction of brain injury and improve targeted interventions.15
The consistent evidence linking abnormal Doppler measures to an increased risk of brain injury in FGR fetuses underscores the necessity of integrating these assessments into routine antenatal care. For obstetricians, this is not merely an academic exercise; it is a direct call to action to refine surveillance protocols. Relying solely on growth parameters misses a critical window for intervention. The cerebroplacental ratio, in particular, offers a sensitive, non-invasive marker that can stratify risk and inform the delicate balance of when to deliver a compromised fetus, potentially reducing the burden of neurodevelopmental impairment.
The implications for patient care are substantial. Early identification of fetuses at high risk allows for more targeted counselling of parents regarding potential neonatal outcomes and facilitates preparation for specialised neonatal care. This proactive approach can lead to improved resource allocation in tertiary centres and better preparedness for the challenges of managing preterm FGR infants. While the technology is widely available, ensuring consistent training and adherence to standardised protocols for Doppler interpretation across all levels of care remains a practical challenge that guideline bodies like NICE and ACOG should address with updated recommendations.
From an industry perspective, the continued reliance on established, cost-effective technologies like Doppler ultrasound highlights the enduring value of foundational diagnostic tools. While there is a constant push for novel biomarkers and advanced imaging, the data reinforce that optimising the application of existing, accessible methods can yield significant clinical gains. Investment in training programmes and quality assurance for ultrasound practitioners may be more impactful in the short term than chasing the next 'breakthrough' technology that may not be widely implementable.
- The Pivot Doppler assessment of the cerebroplacental ratio (CPR) and middle cerebral artery (MCA) pulsatility index (PI) provides a non-invasive method to stratify brain injury risk in FGR.
- The Data Abnormal CPR and MCA PI are associated with an increased incidence of white matter injury and intraventricular haemorrhage in FGR.
- The Action Clinicians should integrate Doppler assessment into the routine monitoring of FGR pregnancies to inform delivery timing and neonatal management.
ART-2026-220
Cite This Article
Team TLSFE. Doppler measures identify brain injury risk in fetal growth restriction. The Life Science Feed. Updated June 9, 2026. Accessed June 9, 2026. https://thelifesciencefeed.com/obstetrics-and-gyn/pregnancy-complications/research/doppler-measures-spot-brain-risk-fgr.
Licence & Rights
© 2026 The Life Science Feed. All rights reserved. Unless otherwise indicated, all content is the property of The Life Science Feed and may not be reproduced, distributed, or transmitted in any form or by any means without prior written permission.
Medical Disclaimer
Editorial & AI Standards
All content is researched from peer-reviewed, open-access sources — published trial data, clinical guidelines, and regulatory filings. AI tools are used solely to structure and summarise that evidence; no AI-generated conclusions appear without editor verification against the primary source.
Every article is reviewed by a named editor before publication. Source citations are listed in the References section. This content does not represent the views of any pharmaceutical company, medical device manufacturer, or healthcare provider.
References
1. Unterscheider J, Daly S, Geary MP, et al. Optimizing the definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol. 2013;42(3):296-300.
2. Kingdom JC, Kaufmann P. Oxygen and placental villous development: origins of fetal hypoxia. Placenta. 1997;18(7):605-612.
3. Baschat AA, Gembruch U, Harman CR. The cerebroplacental ratio revisited. Ultrasound Obstet Gynecol. 2001;17(2):189-191.
4. Figueras F, Gardosi J. Intrauterine growth restriction: new concepts in antenatal surveillance, diagnosis, and management. Am J Obstet Gynecol. 2011;204(4):288-300.
5. Mari G, Deter RL, Carpenter RL, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med. 2000;342(1):9-14.
6. Baschat AA. The cerebroplacental ratio: is it the holy grail? Ultrasound Obstet Gynecol. 2013;42(3):263-265.
7. Prior T, Mullins E, Bennett P, et al. Prediction of stillbirth and adverse perinatal outcomes in fetal growth restriction: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2013;41(3):285-294.
8. Cruz-Martinez R, Figueras F, Oros D, et al. Fetal brain Doppler to predict neonatal brain injury in severe preterm fetal growth restriction. Ultrasound Obstet Gynecol. 2011;38(3):294-298.
9. Volpe JJ. Brain injury in the premature infant: from pathogenesis to prevention. Brain. 2009;132(Pt 6):1388-1411.
10. Karsdorp VH, van Vugt JM, van Geijn HP. Clinical significance of absent or reversed end diastolic flow in the umbilical artery. Lancet. 1994;344(8932):1056-1060.
11. Grivell RM, Dodd JM, Robinson JS. Antenatal surveillance in pregnancies with suspected fetal compromise: a systematic review and meta-analysis. Cochrane Database Syst Rev. 2012;(6):CD007128.
12. Baschat AA. Fetal growth restriction: definitions, diagnosis, and management. Semin Perinatol. 2011;35(5):235-245.
13. Bhide A, Acharya G, Bilardo CM, et al. ISUOG Practice Guidelines: use of Doppler ultrasonography in obstetrics. Ultrasound Obstet Gynecol. 2023;61(1):151-167.
14. Gardosi J, Chang A, Kalyan B, et al. Customised antenatal growth charts. Lancet. 1992;339(8788):283-287.
15. Story L, Gholipour F, Garel C, et al. Fetal brain magnetic resonance imaging in growth restriction: a systematic review. Ultrasound Obstet Gynecol. 2021;58(2):188-199.
